Statistics

Total Visits

Views
EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER46

Select a period of time:

Number of views in the range

Views
EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER27

Views

Views
November 20242
December 20240
January 20258
February 20250
March 202516
April 20251
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States5
United Kingdom3
Chile2
Spain1
 

Top cities views

Views
London3
Alexandria2
Los Angeles2
Santiago Metropolitan2